Pediatrics international : official journal of the Japan Pediatric Society · 2025
Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakamura Tatsuro, Nakagawa Shunsuke, Horikawa Shogo, Nagahama Jun, Yasudome Yuki, Abematsu Takanari, Kodama Yuichi, Nishikawa Takuro, Okamoto Yasuhiro
Аннотация
BACKGROUND: Children with developmental disabilities (DDs) tend to have more fear of loud noises and needles than those without. However, how DDs affect sedation during painful procedures in pediatric patients with cancer is unclear. This study aimed to evaluate the sedative doses and adverse events (AEs) associated with sedation using a combination of midazolam and ketamine for bone marrow aspiration and intrathecal therapy.
METHODS: The AEs evaluated included hypoxia, vomiting, tremors, excitement, disturbances, apnea, and bradycardia. The study included seven participants with autism spectrum disorder, attention deficit hyperactivity disorder, and specific learning disorders, alongside 30 control participants without DD. The types of cancers included acute lymphoblastic leukemia, acute myeloid leukemia, and diffuse large B-cell lymphoma. A total of 107 procedures were performed in the DD group and 378 in the control group.
RESULTS: There were no significant differences in the sedative doses and AEs between patients with DD and controls, except for increased tremors after sedation in the DD group.
CONCLUSIONS: Sedation using a combination of midazolam and ketamine can be safely performed for painful procedures in pediatric patients with cancer and DD without excessive concern.
METHODS: The AEs evaluated included hypoxia, vomiting, tremors, excitement, disturbances, apnea, and bradycardia. The study included seven participants with autism spectrum disorder, attention deficit hyperactivity disorder, and specific learning disorders, alongside 30 control participants without DD. The types of cancers included acute lymphoblastic leukemia, acute myeloid leukemia, and diffuse large B-cell lymphoma. A total of 107 procedures were performed in the DD group and 378 in the control group.
RESULTS: There were no significant differences in the sedative doses and AEs between patients with DD and controls, except for increased tremors after sedation in the DD group.
CONCLUSIONS: Sedation using a combination of midazolam and ketamine can be safely performed for painful procedures in pediatric patients with cancer and DD without excessive concern.